140 related articles for article (PubMed ID: 15288290)
1. Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Sung L; Anderson JR; Donaldson SS; Spunt SL; Crist WM; Pappo AS;
Eur J Cancer; 2004 Aug; 40(12):1878-85. PubMed ID: 15288290
[TBL] [Abstract][Full Text] [Related]
2. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
3. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
[TBL] [Abstract][Full Text] [Related]
4. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
[TBL] [Abstract][Full Text] [Related]
5. [The multidisciplinary treatment of rhabdomyosarcoma in childhood. A 10-year multicenter experience (1978-1988) in Liguria].
Vitali ML; Ricci G; Acquaviva A; Neri E; Cominetti M; Tomassini E; Boni L; Rasore-Quartino A; Bistolfi F; De Bernardi B
Pediatr Med Chir; 1993; 15(3):279-85. PubMed ID: 7692428
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV.
Sung L; Anderson JR; Arndt C; Raney RB; Meyer WH; Pappo AS
J Pediatr; 2004 May; 144(5):666-8. PubMed ID: 15127010
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Spunt SL; Smith LM; Ruymann FB; Qualman SJ; Donaldson SS; Rodeberg DA; Anderson JR; Crist WM; Link MP
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6072-9. PubMed ID: 15447992
[TBL] [Abstract][Full Text] [Related]
8. Predictors of outcome in children and adolescents with rhabdomyosarcoma of the trunk--the St Jude Children's Research Hospital experience.
Chui CH; Billups CA; Pappo AS; Rao BN; Spunt SL
J Pediatr Surg; 2005 Nov; 40(11):1691-5. PubMed ID: 16291153
[TBL] [Abstract][Full Text] [Related]
9. Long-term results in childhood rhabdomyosarcoma: a report from the Italian Cooperative Study RMS 79.
Bisogno G; Pastore G; Perilongo G; Sotti G; Cecchetto G; Dallorso S; Carli M
Pediatr Blood Cancer; 2012 Jun; 58(6):872-6. PubMed ID: 22028198
[TBL] [Abstract][Full Text] [Related]
10. Treatment of childhood rhabdomyosarcoma at St. Jude Children's Research Hospital, 1962--78.
Pratt CB; Hustu HO; Kumar AP; Johnson WW; Ransom JL; Howarth CB; George SL
Natl Cancer Inst Monogr; 1981 Apr; (56):93-101. PubMed ID: 7029301
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV.
Rodeberg D; Arndt C; Breneman J; Lyden E; Donaldson S; Paidas C; Andrassy R; Meyer W; Wiener E
J Pediatr Surg; 2005 Jan; 40(1):256-62. PubMed ID: 15868594
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee.
Bisogno G; Compostella A; Ferrari A; Pastore G; Cecchetto G; Garaventa A; Indolfi P; De Sio L; Carli M
Cancer; 2012 Feb; 118(3):821-7. PubMed ID: 21751206
[TBL] [Abstract][Full Text] [Related]
13. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma.
Mazzoleni S; Bisogno G; Garaventa A; Cecchetto G; Ferrari A; Sotti G; Donfrancesco A; Madon E; Casula L; Carli M;
Cancer; 2005 Jul; 104(1):183-90. PubMed ID: 15895378
[TBL] [Abstract][Full Text] [Related]
15. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
16. Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study.
Nicolin G; Taylor R; Baughan C; Shannon R; Stevens S; Richardson D; Kelsey A; Pritchard-Jones K; Mitchell C
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):175-80. PubMed ID: 17980506
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in children with rhabdomyosarcoma.
Gehan EA; Glover FN; Maurer HM; Sutow WW; Hays DM; Lawrence W; Newton WA; Soule EH
Natl Cancer Inst Monogr; 1981 Apr; (56):83-92. PubMed ID: 7029299
[TBL] [Abstract][Full Text] [Related]
18. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?
Mattke AC; Bailey EJ; Schuck A; Dantonello T; Leuschner I; Klingebiel T; Treuner J; Koscielniak E
Pediatr Blood Cancer; 2009 Jul; 52(7):772-6. PubMed ID: 19165889
[TBL] [Abstract][Full Text] [Related]
19. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors.
Spunt SL; Sweeney TA; Hudson MM; Billups CA; Krasin MJ; Hester AL
J Clin Oncol; 2005 Oct; 23(28):7143-51. PubMed ID: 16192598
[TBL] [Abstract][Full Text] [Related]
20. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Orbach D; Rey A; Oberlin O; Sanchez de Toledo J; Terrier-Lacombe MJ; van Unnik A; Quintana E; Stevens MC
J Clin Oncol; 2005 Jul; 23(19):4363-71. PubMed ID: 15994146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
